Perioperative medicine & outcomes

Surgical Outcome Risk Tool (SORT) to predict 30-day postoperative mortality in a mixed surgical population in Swedish tertiary hospitals

Br J SurgPublished External validation study of a risk prediction model

Authors' conclusion

The estimates of the original the SORT for prediction of 30-day mortality were valid and reliable in a mixed-case surgical population in a non-UK European setting.

Study context

Population
Adults (≥18 years), ASA-PS I–V, non-cardiac surgery at four Swedish tertiary hospitals, November 2015 to February 2016; surgery under local anaesthesia excludedvalidation cohort
Participants
17,965 adults
Outcome
30-day mortality (SORT discrimination by AUROC and calibration)
Follow-up
30 days
Methodological detailsmulticentre, four tertiary hospitals, sensitivity analysis in high-risk subgroup
  • Multicentre
  • Four tertiary hospitals
  • Sensitivity analysis in high-risk subgroup

Performance

As reported in the abstract

Prediction of 30-day mortality
Test or modelArea under the receiver operating curve (AUROC)
SORT0.91 (95 per cent c.i. 0.89 to 0.92)

SORT

Area under the receiver operating curve (AUROC)0.91 (95 per cent c.i. 0.89 to 0.92)
30-day mortality rate
1.6 per cent

Further findings

OutcomeValues
Prediction of 30-day mortality, high-risk subgroup (sensitivity analysis)SORT AUROC 0.79 (0.74 to 0.83)
Prediction of 30-day mortality, high-risk subgroup (sensitivity analysis) — 30-day mortality rate
5.6 per cent
  • Prediction of 30-day mortality, high-risk subgroup (sensitivity analysis): 1807 patients

Prediction of 30-day mortality, high-risk subgroup (sensitivity analysis)

Calibration remained good

Original publication

Surgical Outcome Risk Tool (SORT) to predict 30-day postoperative mortality in a mixed surgical population in Swedish tertiary hospitals. Br J Surg. Published 10 March 2023. doi:10.1093/bjs/znad039

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.